Trade ADMA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
ADMA Biologics Inc (ADMA) is trading at US$9.23, down 1.70% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$2.2B. Over the past 52 weeks, ADMA has traded between US$7.21 and US$20.46. On Syfe you can trade ADMA with $0 commission and add it to your watchlist.
| Previous close | US$9.39 |
|---|---|
| Market cap | US$2.2B |
| P/E ratio | 10.26 |
| 52-week range | US$7.21 – US$20.46 |
| Volume | 2.2M |
| Exchange | US |
Add to Watchlist
Set Price Alert
ADMA Biologics Inc
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.
Year: 2013
-- Earnings Flash (ADMA) ADMA Biologics, Inc. Reports Q2 Revenue $124.4M, vs. FactSet Est of $125.3M
Aug 5, 8:19 PM · MT Newswires
Adma Biologics Q1 Earnings Rise, Revenue Falls; 2026 Sales Outlook Revised -- Shares Down Pre-Bell
May 7, 9:36 AM · MT Newswires
-- Earnings Flash (ADMA) ADMA Biologics, Inc. Reports Q1 Revenue $114.5M, vs. FactSet Est of $140.0M
May 6, 8:21 PM · MT Newswires
Sector Update: Health Care Stocks Flat to Lower Premarket Monday
May 4, 1:19 PM · MT Newswires
ADMA Biologics Receives FDA Approval to Expand Asceniv Label for Pediatric Patients
May 4, 11:37 AM · MT Newswires
ADMA Biologics Inc (ADMA) stock is trading at US$9.23, -1.70% from the previous close of US$9.39.
The market cap for ADMA Biologics Inc (ADMA) stock is approximately US$2.2B.
The price-to-earnings ratio for ADMA Biologics Inc (ADMA) is 10.26, based on the latest reported earnings.
The 52-week high for ADMA Biologics Inc (ADMA) stock is US$20.46.
The 52-week low for ADMA Biologics Inc (ADMA) stock is US$7.21.
ADMA Biologics Inc (ADMA) does not currently pay a dividend.
Stay on top of ADMA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
